During the past decade, University Hospital Münster conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 8 clinical trials were completed, i.e. on average, 12.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 1 clinical trials were completed. i.e. 2.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Münster" #1 sponsor was "University Hospital Muenster" with 28 trials, followed by "Philogen S.p.A." with 4 trials sponsored, "Goethe University" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "Guard Therapeutics AB" with 2 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Münster" #1 collaborator was "Hannover Medical School" with 4 trials as a collaborator, "Amsterdam UMC, location VUmc" with 3 trials as a collaborator, "Federico II University" with 3 trials as a collaborator, "Hospital Vall d'Hebron" with 3 trials as a collaborator and "KU Leuven" with 3 trials as a collaborator. Other collaborators include 184 different institutions and companies that were collaborators in the rest 147 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Münster" are "Endometriosis" (6 trials), "Sepsis" (5 trials), "Acute Kidney Injury" (4 trials), "Inflammatory Bowel Diseases" (3 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "University Hospital Münster" in a lesser frequency.

Most popular intervention types in "University Hospital Münster" are "Drug" (33 trials), "Other" (18 trials), "Device" (15 trials), "Procedure" (7 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "F16IL2" (2 trials), "MRI" (2 trials), "RMC-035" (2 trials) and "(1,3)-β-D-glucan guided therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Münster" are 75 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Münster". undefined are not yet recruiting, 20 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in University Hospital Münster, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Münster, 5 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".